PAR

1.92%

25.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-56

First 56 Last

Share
Profile

Follow
Gan_Gans

2,084 Posts.

562

06/04/24

17:45

Post #: 73221475
Share

Originally posted by 39KP: ↑

hi GG.

This is what Mozz and others were mentioning. from what I have heard, due to the volume of data and new data that hasn't been in previous submissions the fda have asked that we do an RFI. this takes a little longer than the standard 30 day response we normally get we are FT.

now some will say this is negative and hence we will run out of money and the sky is falling etc. Others will say it's great as we have lots of new things to discuss and it will help with breakthrough etc. I don't know what to think so I am sitting on my hands and waiting for the fda to get back to par and for par to tell us, as they will be legally obliged to.

I have heard that the potential response is in June. but if it's later then it's the fda not par slowing things down and 'missing deadlines'. I think there is a chance we may have a bit of extended back and forth here.

next question - implications for a deal and funding due to the delay ? no deal pre fda reply is a pretty good assumption to my mind.

funding ? well similar to a deal.

so we run out of money in 3 months ? well no. I am quite sure they are working on funding.

so bad news from fda or big delays I think will be a serious issue clearly as we need funding clearly. if we get the things the so called 'fanboys' are hoping for, ie reduced numbers / BT pathway well then I would expect the mood to pick up on HC.

I'm nervous for sure but holding in the hopes the fda (who surely know we are short on cash) went this drug developed and hence we find a path forward in the next 6 months.

I could be wrong and it all goes pear shaped. for those long term investors, we need a bit of luck and a little
more patience. let's hope we are right.

Expand

none of this has been announced to the market, from my understanding

PAR Price at posting: 33.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

RCE

Recce's R327 found effective against E.coli during clinical trial

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

There are more pages in this discussion • 566 more messages in this thread...

First 56 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change -0.005(1.92%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
27.0¢	27.0¢	25.5¢	$261.4K	990.7K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	9445	1

View Market Depth

No.	Vol.	Price($)
1	9999	0.255
5	259000	0.250
4	96000	0.245
9	261374	0.240
5	71970	0.235

Price($)	Vol.	No.
0.260	9445	1
0.275	44000	2
0.280	35900	3
0.285	6729	2
0.290	60000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PAR (ASX) Chart

Where we at?, page-56

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Where we at?, page-56

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News